Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Colonoscopy & upper endoscopy · Rhode Island | Colonoscopy & upper endoscopy · New York | |
|---|---|---|
| Surgeons, 2024 | 62 | 1,378 |
| Medicare fee-for-service cases | 12,155 | 235,327 |
| Growth since 2019 (Medicare FFS) | −5.7%/yr | −1.7%/yr |
| Forecast cases (Medicare FFS) | 12,900 in 2030 | 246,900 in 2030 |
| Forecast growth | +1%/yr to 2030 | +0.8%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 139.8 | 134.5 |
| Medicare Advantage share | 66% | 57% |
| Out of hospital | 57% (+4 pts since 2019) | 54% (−2 pts since 2019) |
| Cases per surgeon | 196 | 171 |
| Top 10 surgeons' share | 36% | 4% |
| Surgeons growing | 14 | 405 |
| New since the base year | 9 | 195 |
| Likely to stop billing it | 4 by 2026 | 75 by 2026 |
| Forecast miss, 1 year (procedure) | 1% | 1% |
| Company payments per surgeon | $39 | $276 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.